← SynDRA
SR-2640
SynDRA canonical compound SYN0001061 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CYSLTR1 |
|---|
| Mechanism of action | Leukotriene receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Leukotriene receptor antagonist
- CYSLTR1 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- PMP22
- KDM4E
- L3MBTL1
- LMNA
- MAPK1
- MAPT
- MPHOSPH8
- NPC1
- POLH
- ARSA
- POLI
- POLK
- RGS4
- TDP1
- THPO
- TP53
- TSHR
- KDM4A
- KAT2A
- HSD17B10
- HIF1A
- ATAD5
- BAZ2B
- BLM
- CBX1
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- DRD1
- EHMT2
- ERG
- FEN1
- GMNN
- HDAC6
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ADCY9
- CP1A2
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
- PAFA
- PPME1
- YAP1
Cross-references
Synonyms
- SR 2640
- SR 2640 Hydrochloride
- CHEMBL18132
- SR2640
- Benzoic acid, 2-[[3-(2-quinolinylmethoxy)phenyl]amino]-
- QMPB
- Benzoic acid, 2-((3-(2-quinolinylmethoxy)phenyl)amino)-
- SR-01000076219
- Tocris-1804
- Lopac-S-7690
- AC1L2TN9
- Lopac0_001079
- 2-(3-(2-Quinolylmethoxy)phenylamino)benzoic acid
- MLS002153402
- cid_128355
- GTPL3329
- SCHEMBL9119607
- CTK8F0698
- CHEBI:104023
- HMS3263G20
- HMS2236C03
- ZINC596951
- HMS3373N15
- Tox21_501079
- BDBM50006798
- AKOS030239522
- LP01079
- CCG-205156
- NCGC00015965-02
- NCGC00015965-04
- 2-((3-(Quinolin-2-ylmethoxy)phenyl)amino)benzoic acid
- 2-{[3-(quinolin-2-ylmethoxy)phenyl]amino}benzoic acid
- RefChem:185179
- 2-[3-(quinolin-2-ylmethoxy)anilino]benzoic acid
- SR2640 hydrochloride?
- orb2945521
- SCHEMBL29767038
- SCHEMBL31327545
- EX-A7220
Look up SR-2640 in the interactive SynDRA portal →